· CEPI to provide up to $4.98 USD million to Houston Methodist Research Institute-led consortium to use artificial intelligence for design of vaccines to fight diseases with pandemic potential.
· The project will support a consortium, led by HMRI, to design potential antigenic targets for up to 10 priority virus families with epidemic or pandemic potential. Laboratory-based tests will then be used to verify antigen designs for possible further development.
· Consortium will include The University of Texas, Austin, The University of Texas Medical Branch, J Craig Venter Research Institute, La Jolla Institute, and Argonne National Laboratory (University of Chicago).
CEPI, the Coalition for Epidemic Preparedness Innovations, and the Houston Methodist Research Institute (HMRI), have today announced a partnership to combine cutting-edge artificial intelligence (AI) technology with established laboratory techniques to speed up development of future vaccines against novel viral threats (also known as Disease X).
COVID-19 vaccines were developed in record time because scientists were already working on vaccines against related viruses. Dr Melanie Saville from the Coalition for Epidemic Preparedness Innovations (CEPI) explains how a similar approach could yield vaccines against future viral threats.
SANUWAVE Health (OTCMKTS:SNWV – Free Report) and AVITA Medical (NASDAQ:RCEL – Free Report) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their profitability, institutional ownership, earnings, analyst recommendations, risk, dividends and valuation. Insider & Institutional Ownership 7.5% of SANUWAVE Health shares […]